Home
All topics: A to Z
COVID-19
Prevention and control
Patient and case management

COVID-19 vaccination
Efficacy, effectiveness and safety of vaccines against COVID-19
Non-pharmaceutical interventions
Contact tracing
Guidance on quarantine and isolation
How to protect yourself
Risk groups
Patient and case management
Long-term care facilities

Patient and case management for COVID-19

ECDC resources on patient and case management for COVID-19, including protective equipment, diagnosis, prevention and vaccines.

Patient/case management
Diagnosis
Protective equipment
Vaccines

Technical report - 28 Jan 2022

Technical report - 28 Oct 2021

Technical report - 9 Feb 2021

Technical report - 19 Oct 2020

Technical report - 3 Jul 2020

Load More

Technical report - 14 Feb 2022

Technical report - 10 Feb 2022

Technical report - 26 Oct 2021

Technical report - 6 May 2021

Technical report - 3 May 2021

Load More

Technical report - 7 Feb 2022

Technical report - 24 Sep 2020

Risk assessment - 10 Aug 2020

Infographic - 3 Jul 2020

Technical report - 2 Jul 2020

Load More

Technical report - 28 Apr 2022

Technical report - 21 Apr 2022

Technical report - 14 Mar 2022

Technical report - 10 Feb 2022

Technical report - 8 Feb 2022

Load More

Case management
COVID-19

Patient and case management for COVID-19

Patient and case management for COVID-19

Guidance on ending the isolation period for people with COVID-19, third update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Infection prevention and control and preparedness for COVID-19 in healthcare settings - sixth update

COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

Case definition for coronavirus disease 2019 (COVID-19), as of 3 December 2020

Diagnostic testing and screening for SARS-CoV-2

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

Considerations for the use of saliva as sample material for COVID-19 testing

Non-pharmaceutical interventions against COVID-19

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eleventh update: resurgence of cases

Infographic: Use of gloves in healthcare and non-healthcare settings in the context of COVID-19

Use of gloves in healthcare and non-healthcare settings in the context of the COVID 19 pandemic

Treatment and pharmaceutical prophylaxis of COVID-19

Vaccination Portal : COVID-19 vaccines

COVID-19 vaccination

Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose

Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update

Considerations for the use of antibody tests for SARS-CoV-2 – first update

COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose

About us

Work with us

Contact ECDC

Follow us: